Bausch + Lomb Corp will pay $1.75 billion to acquire a dry-eye drug from Swiss pharmaceutical giant Novartis, the Wall Street Journal reported on Friday.
(Reporting by Leroy Leo in Bengaluru; Editing by Anil D'Silva)
Bausch + Lomb to buy dry-eye drug from Novartis for $1.75 billion - WSJ
2023-06-30 11:12
Bausch + Lomb Corp will pay $1.75 billion to acquire a dry-eye drug from Swiss pharmaceutical giant Novartis,
You Might Like...
Bank of England to review how it stress tests banks
Australia fines Musk's X platform $386,000 over anti-child abuse gaps
X CEO Yaccarino tells bank lenders that revenue grew by single-digit percentage -source
Canada gains 39,900 jobs in August, jobless rate holds at 5.5%
Asia shares edge higher, China disinflation a drag
What is Jennifer Pedranti's net worth? Inside 'RHOC’ Season 17 star's complicated personal life and philanthropic acts
Tribute Honors Gordon Moore, Intel’s Co-Founder
Blue Star Families and Nextdoor Partner to Welcome Military Families on the Move